Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Fenretinide × Clear all

NCT00080899 2015-03-06

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Phase 2 Completed

23 enrolled 3 charts

Prostatic Neoplasms

NCT00077402 2013-05-15

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms